U.S. lawmakers are set to vote this week on over two dozen bills aimed at tightening restrictions on Chinese tech, trade, and diplomacy—a move critics call a politically charged distraction. Dubbed 'China Week,' the proposed legislation includes bans on federal contracts with major Chinese biotech firms like BGI Group and Wuxi AppTec, stricter oversight of drones and cranes made in China, and the potential closure of Hong Kong's economic offices in the U.S.
What’s in the Bills?
The Biosecure Act, a key focus of the legislative blitz, singles out five Chinese companies without disclosing the selection criteria—raising concerns about transparency. Supporters argue the measures protect national security, but opponents see them as efforts to stifle China's economic growth. House Speaker Mike Johnson previously urged Congress to 'counter China with every tool,' framing the push as strategic.
A Question of Motives
Analysts suggest the bills rely on vague claims about 'threats' to justify sweeping policies. Critics compare the approach to past trade wars, warning it could escalate tensions without clear benefits for Americans. Meanwhile, U.S.-based firms worry about disruptions to global supply chains.
As debates heat up, the world watches: Will 'China Week' redefine competition—or deepen divides?
Shanghai-Hong Kong Stock Connect Turns 10:…
